Online Pharmacy Market in India 2023
Indian pharma retail market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical conditions and emergence of new diseases help increase the demand for various medicines. Online pharmacy market in India is expected to see a steady growth with the rising high-speed internet penetration, rising smartphone and e-commerce usage.
As per NAVADHI Market Research, the Indian online pharmacy industry will we worth USD 2.35 billion and will have a market share of 7.08% in India’s pharmaceuticals market by 2023. The growth in this market is predicted on the basis of various factors like market drivers, current and upcoming trends, current growth pattern, and market challenges.
To know more about this newly launched market research report visit “Online Pharmacy Market in India 2023”
This growth is fueled by the growing and ageing population in India. More than 6% of Indian population is above 65 years of age and this number is expected to rise by 2023. Apart from ageing and rising population the improvements in purchasing power and access to quality healthcare and pharmaceuticals to poor and middle-class families is also driving the growth of Indian pharma industry. Indian people spend 64.21% of their health expenditure from out-of-pocket of which pharmaceuticals spend accounts for 51.67%. Increased access to high speed internet and rising smartphone usage had made it possible to access e-commerce websites even in rural and remote areas of India. This along with ease of use, home-delivery of medicines, no fear of counterfeit medicines and around 15-20% discount on MRP of medicines offered by online pharmacies are bigger draw for consumers.
On the other hand, lack of any regulatory framework for the e-pharmacy market is the major growth inhibitor for online pharmacy market in India. In August 2018, the Union Health Ministry come out with draft rules amendments to the Drugs and Cosmetics Act on sale of drugs by e-pharmacies in India with an aim to regulate online sale of medicines and provide patients accessibility to genuine drugs from authentic online portals. The newly re-elected Mr. Narendra Modi government has planned to finalize online pharmacy rules it it’s 100-day agenda.
In December 2018, the Delhi high court ordered all e-pharmacies in the country to close their operations by 20th December 2018. In the same month, the Madras high court acting on an appeal filed by a group of online pharmacy companies suspended the ban.
As India’s online phamacy it is expected to eat into the market share of traditional brick-and-mortar pharma retail market. Brick-and-mortar pharma retailers who make up over eight lakh of the country’s voter base have opposed the move to allow e-pharmacies to sell medicines, arguing easy availability of drugs can lead to misuse.
Aggressive drug price control mechanism like Government mandated drug price controls using drug price control order (DPCO) which is an order issued by the Government of India under Section 3 of the Essential Commodities Act, 1955 empowering it to fix and regulate the prices of essential bulk drugs and their formulations have increased the margin pressure for pharma retail companies in India. This can have adverse impact on online pharmacies as they need to heavily invest in technology, operations and logistics. They also rely on offering heavy discounts to customers to gain market share which may not be possible under eroding margins. This can lead to same situation as faced by major consumer e-commerce players in India like Amazon, Flipkart etc.
Also government operated Jan Aushadhi Kendra (pharmacy stores) which offer medicines at discounted rates are expected to give tough competition to online pharma stores which can affect their profit margins. Timely availability of critical care medicines especially in Tier-II, III and IV markets are a major challenge for online pharmacies in India. To tackle this challenge players like NetMeds are planning to setup brick-and-mortar pharmacies themselves.
Spanning over 68 pages and 37 exhibits, “Online Pharmacy Market in India 2023” report provides in-depth analysis for the Indian online pharmacy market for the year FY2018 to FY2023, including market structure, market trends, market constraints and industry drivers.
Scope of the Online Pharmacy Market in India 2023 Report
As per NAVADHI Market Research, the Indian online pharmacy industry will we worth USD 2.35 billion and will have a market share of 7.08% in India’s pharmaceuticals market by 2023. The growth in this market is predicted on the basis of various factors like market drivers, current and upcoming trends, current growth pattern, and market challenges.
To know more about this newly launched market research report visit “Online Pharmacy Market in India 2023”
This growth is fueled by the growing and ageing population in India. More than 6% of Indian population is above 65 years of age and this number is expected to rise by 2023. Apart from ageing and rising population the improvements in purchasing power and access to quality healthcare and pharmaceuticals to poor and middle-class families is also driving the growth of Indian pharma industry. Indian people spend 64.21% of their health expenditure from out-of-pocket of which pharmaceuticals spend accounts for 51.67%. Increased access to high speed internet and rising smartphone usage had made it possible to access e-commerce websites even in rural and remote areas of India. This along with ease of use, home-delivery of medicines, no fear of counterfeit medicines and around 15-20% discount on MRP of medicines offered by online pharmacies are bigger draw for consumers.
On the other hand, lack of any regulatory framework for the e-pharmacy market is the major growth inhibitor for online pharmacy market in India. In August 2018, the Union Health Ministry come out with draft rules amendments to the Drugs and Cosmetics Act on sale of drugs by e-pharmacies in India with an aim to regulate online sale of medicines and provide patients accessibility to genuine drugs from authentic online portals. The newly re-elected Mr. Narendra Modi government has planned to finalize online pharmacy rules it it’s 100-day agenda.
In December 2018, the Delhi high court ordered all e-pharmacies in the country to close their operations by 20th December 2018. In the same month, the Madras high court acting on an appeal filed by a group of online pharmacy companies suspended the ban.
As India’s online phamacy it is expected to eat into the market share of traditional brick-and-mortar pharma retail market. Brick-and-mortar pharma retailers who make up over eight lakh of the country’s voter base have opposed the move to allow e-pharmacies to sell medicines, arguing easy availability of drugs can lead to misuse.
Aggressive drug price control mechanism like Government mandated drug price controls using drug price control order (DPCO) which is an order issued by the Government of India under Section 3 of the Essential Commodities Act, 1955 empowering it to fix and regulate the prices of essential bulk drugs and their formulations have increased the margin pressure for pharma retail companies in India. This can have adverse impact on online pharmacies as they need to heavily invest in technology, operations and logistics. They also rely on offering heavy discounts to customers to gain market share which may not be possible under eroding margins. This can lead to same situation as faced by major consumer e-commerce players in India like Amazon, Flipkart etc.
Also government operated Jan Aushadhi Kendra (pharmacy stores) which offer medicines at discounted rates are expected to give tough competition to online pharma stores which can affect their profit margins. Timely availability of critical care medicines especially in Tier-II, III and IV markets are a major challenge for online pharmacies in India. To tackle this challenge players like NetMeds are planning to setup brick-and-mortar pharmacies themselves.
Spanning over 68 pages and 37 exhibits, “Online Pharmacy Market in India 2023” report provides in-depth analysis for the Indian online pharmacy market for the year FY2018 to FY2023, including market structure, market trends, market constraints and industry drivers.
Scope of the Online Pharmacy Market in India 2023 Report
- This report provides detailed information about Indian online pharmacy market including future market forecasts up to 2023.
- This report identifies the need for focusing on Indian pharmaceuticals market
- The report identifies the growth drivers and inhibitors for Indian online pharmacy market.
- This report provides information about policies related to online pharmacy industry in India.
- This report provides information about industry associations and government bodies related to Indian pharmaceuticals industry.
- The report identifies various risks associated with Indian online pharmacy market.
- This report has detailed profiles 3 key players in Indian pharma retail market covering their position in pharma retail value chain, business strategy and SWOT analysis.
- This report provides PESTEL (political, economic, social, technological, environmental and legal) analysis for Indian pharmaceuticals market.
- This report provides Porter’s Five Forces analysis for Indian pharmacy retail market.
- This report provides SWOT (strengths, weakness, opportunities and threats) analysis for Indian online pharmacy market.
- This report provides information about future trends in Indian online pharmacy market.
1. EXECUTIVE SUMMARY
Scope of the Online Pharmacy Market in India 2023 Report
Research Methodology
2. INTRODUCTION OF INDIAN PHARMACEUTICALS MARKET
Key Product Terms Used in Pharmaceuticals Industry
Pharmaceuticals
Innovative Drugs
Orphan Drugs
Generic Drugs
Commodity Generic Drugs
Branded Generic Drugs
Biologics
Biosimilars
Over-the-counter (OTC) Drugs
Active Pharmaceutical Ingredients (APIs)
Excipients
Research and Development (R&D) Phases of Pharmaceuticals Industry
Industry-Wise Research and Development (R&D) Investment
Phase Wise Research and Development (R&D) Investment in Pharmaceuticals Industry
Indian Pharmaceuticals Industry Value Chain Analysis
3. NEED FOR INDIAN PHARMACEUTICALS MARKET
3.1 Rising & Ageing Population
3.2 Increasing Income Levels of Poor & Middle-Class Families
3.3 Drug Security
4. FORECAST FOR ONLINE PHARMACY MARKET IN INDIA 2023
4.1 Forecast for Online Pharmacy Market in India 2018-2023
4.1.1 Forecast for India Online Pharmacy Market 2018-2023
5. GROWTH DRIVERS AND INHIBITORS FOR ONLINE PHARMACY MARKET IN INDIA
6. POLICIES RELATED TO ONLINE PHARMACY INDUSTRY IN INDIA
6.1 Central Government Policies
6.1.1 Essential Commodities Act 1955
6.1.2 Drugs and Cosmetics Act 1940 (As amended in June 2005)
6.1.3 National Pharmaceutical Pricing Policy 2012
6.1.4 Drug Price Control Orders (DPCO)
6.1.5 Drug Policy 1986
6.1.6 Pharmaceutical Policy - 2002
6.2 Guidelines related to Marketing in Indian Pharmaceuticals Industry
6.3 Highlights of Draft Regulation for e-Pharmacy Market in India
7. INDUSTRY ASSOCIATIONS RELATED TO INDIAN PHARMACEUTICALS MARKET
7.1 Indian Drug Manufacturers' Association (IDMA)
7.2 Indian Pharma Machinery Manufacturers Association (IPMMA)
7.3 Indian Pharmaceutical Association (IPA)
7.4 Organisation of Pharmaceutical Producers of India (OPPI)
7.5 Association of Indian Medical Device Industry (AIMED)
8. GOVERNMENT BODIES RELATED TO INDIAN PHARMACEUTICALS MARKET
8.1 Department of Pharmaceuticals
8.2 Ministry of Chemicals & Fertilizers
8.3 National Pharmaceutical Pricing Authority (NPPA)
9. PROFILE OF KEY PLAYERS IN INDIAN ONLINE PHARMACY MARKET
9.1 PharmEasy
9.1.1. Company Profile
9.1.2 PharmEasy in Pharma Retail Value Chain
9.1.3 PharmEasy Business Strategy
9.1.4 SWOT Analysis of PharmEasy
Strengths
Weaknesses
Opportunities
Threats
9.2 Myra
9.2.1 Company Profile
9.2.2 Myra in Pharma Retail Value chain
9.2.3 Myra Business Strategy
9.2.4 SWOT Analysis of Myra
Strengths
Weaknesses
Opportunities
Threats
9.3 NetMeds Marketplace Limited
9.3.1 Company Profile
9.3.2 NetMeds Marketplace Limited in Pharma Retail Value chain
9.3.3 SWOT Analysis of NetMeds Marketplace Limited
Strengths
Weaknesses
Opportunities
Threats
10. RISKS ASSOCIATED WITH INDIAN ONLINE PHARMACY INDUSTRY
10.1 Credit Risks
10.2 Policy Risk
10.3 Technical Risk
11. ANALYSIS OF ONLINE PHARMACY MARKET IN INDIA
11.1 PESTLE Analysis of India Pharmaceuticals Market
11.2 Porter’s Five Forces Analysis of Indian Online Pharmacy Market
Threat of New Entrants
Threat of Substitutes
Bargaining Power of Suppliers
Bargaining Power of Buyers
Competitive Rivalry
11.3 SWOT Analysis of Indian Online Pharmacy Industry
Strengths
Weaknesses
Opportunities
Threats
12. FUTURE TRENDS IN INDIAN ONLINE PHARMACY MARKET
List of Exhibits
Notes
Company Information
Scope of the Online Pharmacy Market in India 2023 Report
Research Methodology
2. INTRODUCTION OF INDIAN PHARMACEUTICALS MARKET
Key Product Terms Used in Pharmaceuticals Industry
Pharmaceuticals
Innovative Drugs
Orphan Drugs
Generic Drugs
Commodity Generic Drugs
Branded Generic Drugs
Biologics
Biosimilars
Over-the-counter (OTC) Drugs
Active Pharmaceutical Ingredients (APIs)
Excipients
Research and Development (R&D) Phases of Pharmaceuticals Industry
Industry-Wise Research and Development (R&D) Investment
Phase Wise Research and Development (R&D) Investment in Pharmaceuticals Industry
Indian Pharmaceuticals Industry Value Chain Analysis
3. NEED FOR INDIAN PHARMACEUTICALS MARKET
3.1 Rising & Ageing Population
3.2 Increasing Income Levels of Poor & Middle-Class Families
3.3 Drug Security
4. FORECAST FOR ONLINE PHARMACY MARKET IN INDIA 2023
4.1 Forecast for Online Pharmacy Market in India 2018-2023
4.1.1 Forecast for India Online Pharmacy Market 2018-2023
5. GROWTH DRIVERS AND INHIBITORS FOR ONLINE PHARMACY MARKET IN INDIA
6. POLICIES RELATED TO ONLINE PHARMACY INDUSTRY IN INDIA
6.1 Central Government Policies
6.1.1 Essential Commodities Act 1955
6.1.2 Drugs and Cosmetics Act 1940 (As amended in June 2005)
6.1.3 National Pharmaceutical Pricing Policy 2012
6.1.4 Drug Price Control Orders (DPCO)
6.1.5 Drug Policy 1986
6.1.6 Pharmaceutical Policy - 2002
6.2 Guidelines related to Marketing in Indian Pharmaceuticals Industry
6.3 Highlights of Draft Regulation for e-Pharmacy Market in India
7. INDUSTRY ASSOCIATIONS RELATED TO INDIAN PHARMACEUTICALS MARKET
7.1 Indian Drug Manufacturers' Association (IDMA)
7.2 Indian Pharma Machinery Manufacturers Association (IPMMA)
7.3 Indian Pharmaceutical Association (IPA)
7.4 Organisation of Pharmaceutical Producers of India (OPPI)
7.5 Association of Indian Medical Device Industry (AIMED)
8. GOVERNMENT BODIES RELATED TO INDIAN PHARMACEUTICALS MARKET
8.1 Department of Pharmaceuticals
8.2 Ministry of Chemicals & Fertilizers
8.3 National Pharmaceutical Pricing Authority (NPPA)
9. PROFILE OF KEY PLAYERS IN INDIAN ONLINE PHARMACY MARKET
9.1 PharmEasy
9.1.1. Company Profile
9.1.2 PharmEasy in Pharma Retail Value Chain
9.1.3 PharmEasy Business Strategy
9.1.4 SWOT Analysis of PharmEasy
Strengths
Weaknesses
Opportunities
Threats
9.2 Myra
9.2.1 Company Profile
9.2.2 Myra in Pharma Retail Value chain
9.2.3 Myra Business Strategy
9.2.4 SWOT Analysis of Myra
Strengths
Weaknesses
Opportunities
Threats
9.3 NetMeds Marketplace Limited
9.3.1 Company Profile
9.3.2 NetMeds Marketplace Limited in Pharma Retail Value chain
9.3.3 SWOT Analysis of NetMeds Marketplace Limited
Strengths
Weaknesses
Opportunities
Threats
10. RISKS ASSOCIATED WITH INDIAN ONLINE PHARMACY INDUSTRY
10.1 Credit Risks
10.2 Policy Risk
10.3 Technical Risk
11. ANALYSIS OF ONLINE PHARMACY MARKET IN INDIA
11.1 PESTLE Analysis of India Pharmaceuticals Market
11.2 Porter’s Five Forces Analysis of Indian Online Pharmacy Market
Threat of New Entrants
Threat of Substitutes
Bargaining Power of Suppliers
Bargaining Power of Buyers
Competitive Rivalry
11.3 SWOT Analysis of Indian Online Pharmacy Industry
Strengths
Weaknesses
Opportunities
Threats
12. FUTURE TRENDS IN INDIAN ONLINE PHARMACY MARKET
List of Exhibits
Notes
Company Information
LIST OF EXHIBITS
Exhibit 2.1 Research and Development Phases of Pharmaceuticals Industry
Exhibit 2.2 Industry-Wise Research and Development Investment in Comparison to Net Sales (in %)
Exhibit 2.3 Phase-Wise Research and Development Investment in Pharmaceuticals Industry
Exhibit 2.4 Indian Pharmaceuticals Industry Value Chain Analysis
Exhibit 3.1 India Population Forecast 2016-2023 (in millions)
Exhibit 3.2 Purchasing Power Parity Based Per Capita GDP Forecast for India 2016-2023 (in USD)
Exhibit 4.1 Segment-wise Market Share of Indian Pharma Retail (Pharmacy) Market in 2017 (in %)
Exhibit 4.2 Population Forecast for India 2016-2023 (in millions)
Exhibit 4.3 Forecast for India Online Pharmacy Market 2018-2023 (in USD billion)
Exhibit 4.4 Growth Forecast for Online Pharmacy Market in India 2018-2023 (in %)
Exhibit 5.1 Growth Drivers and Inhibitors for Online Pharmacy Market in India
Exhibit 6.1 Code for Marketing practices in Indian Pharmaceuticals Industry
Exhibit 6.2 Highlights of Draft Regulation for e-Pharmacy Market in India
Exhibit 7.1 Key information of IDMA
Exhibit 7.2 Contact details of IDMA
Exhibit 7.3 Key information of IPMMA
Exhibit 7.4 Contact details of IPMMA
Exhibit 7.5 Key Information of IPA
Exhibit 7.6 Contact details of IPA
Exhibit 7.7 Key information of OPPI
Exhibit 7.8 Contact details of OPPI
Exhibit 7.9 Contact information for AIMED
Exhibit 9.1 Key Information of PharmEasy
Exhibit 9.2 Contact information of PharmEasy
Exhibit 9.3 PharmEasy in Pharma Retail Industry Value Chain
Exhibit 9.4 SWOT Analysis of PharmEasy
Exhibit 9.5 Key information of Myra
Exhibit 9.6 Contact Information of Myra
Exhibit 9.7 Myra in Pharma Retail Industry Value Chain
Exhibit 9.8 SWOT Analysis of Myra
Exhibit 9.10 Key information of NetMeds
Exhibit 9.11 Contact Information of NetMeds
Exhibit 9.12 NetMeds in Pharma Retail Industry Value Chain
Exhibit 9.13 SWOT Analysis of NetMeds Marketplace Limited
Exhibit 11.1 PESTEL Analysis of the Indian Pharmaceuticals Industry
Exhibit 11.2 Porter’s Five Forces Analysis for Indian Online Pharmacy Market
Exhibit 11.3 SWOT Analysis of Indian Online Pharmacy Industry
Exhibit 2.1 Research and Development Phases of Pharmaceuticals Industry
Exhibit 2.2 Industry-Wise Research and Development Investment in Comparison to Net Sales (in %)
Exhibit 2.3 Phase-Wise Research and Development Investment in Pharmaceuticals Industry
Exhibit 2.4 Indian Pharmaceuticals Industry Value Chain Analysis
Exhibit 3.1 India Population Forecast 2016-2023 (in millions)
Exhibit 3.2 Purchasing Power Parity Based Per Capita GDP Forecast for India 2016-2023 (in USD)
Exhibit 4.1 Segment-wise Market Share of Indian Pharma Retail (Pharmacy) Market in 2017 (in %)
Exhibit 4.2 Population Forecast for India 2016-2023 (in millions)
Exhibit 4.3 Forecast for India Online Pharmacy Market 2018-2023 (in USD billion)
Exhibit 4.4 Growth Forecast for Online Pharmacy Market in India 2018-2023 (in %)
Exhibit 5.1 Growth Drivers and Inhibitors for Online Pharmacy Market in India
Exhibit 6.1 Code for Marketing practices in Indian Pharmaceuticals Industry
Exhibit 6.2 Highlights of Draft Regulation for e-Pharmacy Market in India
Exhibit 7.1 Key information of IDMA
Exhibit 7.2 Contact details of IDMA
Exhibit 7.3 Key information of IPMMA
Exhibit 7.4 Contact details of IPMMA
Exhibit 7.5 Key Information of IPA
Exhibit 7.6 Contact details of IPA
Exhibit 7.7 Key information of OPPI
Exhibit 7.8 Contact details of OPPI
Exhibit 7.9 Contact information for AIMED
Exhibit 9.1 Key Information of PharmEasy
Exhibit 9.2 Contact information of PharmEasy
Exhibit 9.3 PharmEasy in Pharma Retail Industry Value Chain
Exhibit 9.4 SWOT Analysis of PharmEasy
Exhibit 9.5 Key information of Myra
Exhibit 9.6 Contact Information of Myra
Exhibit 9.7 Myra in Pharma Retail Industry Value Chain
Exhibit 9.8 SWOT Analysis of Myra
Exhibit 9.10 Key information of NetMeds
Exhibit 9.11 Contact Information of NetMeds
Exhibit 9.12 NetMeds in Pharma Retail Industry Value Chain
Exhibit 9.13 SWOT Analysis of NetMeds Marketplace Limited
Exhibit 11.1 PESTEL Analysis of the Indian Pharmaceuticals Industry
Exhibit 11.2 Porter’s Five Forces Analysis for Indian Online Pharmacy Market
Exhibit 11.3 SWOT Analysis of Indian Online Pharmacy Industry
